News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

MDA’s 2022 Advocacy Agenda

By Mark Fisher | January 27, 2022
Blog Post

FDA Approves argenx’s Vyvgart for Treatment of gMG

By Sujatha Gurunathan | December 20, 2021
Blog Post

Muscular Dystrophy Association Awards 18 Grants Totaling Over $1.6 Million for Neuromuscular Disease Research

By Sujatha Gurunathan | November 5, 2021
Blog Post

It’s Open Enrollment Season. Here’s what you need to know!

By Mark Fisher | November 1, 2021
Blog Post

Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD

By Sujatha Gurunathan | September 30, 2021
Blog Post

Clinical Trial Alert: Phase 2 Study of Ifetroban in Individuals with DMD

By MDA Staff | August 18, 2021
Blog Post

Clinical Trial Alert: Phase 2/3 and Open-Label Extension Study of ASP0367 in Individuals with Primary Mitochondrial Myopathy

By MDA Staff | August 9, 2021
Blog Post

FDA Approves Sanofi Genzyme’s Nexviazyme for Treatment of Pompe Disease

By MDA Staff | August 6, 2021
Blog Post

Research Study Alert: Survey for Caregivers of Children with SMA to Study Treatment Decision Making

By MDA Staff | July 30, 2021
Blog Post

Clinical Trial Alert: Phase 1b/2a Study of Descartes-08 in Adults with Generalized Myasthenia Gravis

By MDA Staff | July 30, 2021